Skip to main content
Caplight Logo









Bontia Bio

Bontia Bio

Private
WellingtonHealthcare & Life Scienceshttps://www.bontiabio.com/

Last Round

Grant

Mar 26, 2025

Total Funding Raised

$1.14M

Company Overview

Bontia Bio is a biotechnology company that develops natural and sustainable antiparasitic compounds for animal health and agriculture using a proprietary synthetic biology platform.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

synthetic biologysynbioflea and tick treatmentanimal healthprecision fermentationbiomanufacturingcompanion animal healthanti-parasiticfermentationnatural compoundsbiopesticidessynthetic biology platformnovel mode of actionagritechcrop protectionuniversity spin-out

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bontia Bio Comparables

Compare Bontia Bio with similar companies based on industry and business-model similarity.

Bontia Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ASTRA Therapeutics
76%
Elanco
72%
Merck & Co., Inc.
71%

Bontia Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 26, 2025
SeedMar 26, 2025

Bontia Bio Investors

Notable investors and investment history

Bontia Bio investors
InvestorRounds
Callaghan InnovationGrant
Sprout AgritechSeed
Booster Innovation FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 26, 2025

    $430K raised from Callaghan Innovation.

  • Mar 26, 2025

    $710K round led by Sprout Agritech.

Bontia Bio Filings

Explore SEC and related filing metadata, where available.

Bontia Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bontia Bio's valuation, stock price, and market status.

Is Bontia Bio a public or private company?

Bontia Bio is a private company.

What is the current stock price of Bontia Bio?

Bontia Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Bontia Bio worth (valuation)?

Valuation information for Bontia Bio is not publicly available.

Can I buy Bontia Bio stock?

Bontia Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bontia Bio's last funding round?

Funding round information for Bontia Bio is not publicly available.

Who are the main investors in Bontia Bio?

Investor information for Bontia Bio is not publicly disclosed.

Will Bontia Bio IPO soon?

No public IPO plans have been announced for Bontia Bio.

How can I track Bontia Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bontia Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersWellington
Employee Range5
Year Founded2024
Last FundingMar 26, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?